Labcorp (NYSE: LH) schedules Q1 2026 earnings release and webcast
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Labcorp Holdings Inc. will release its financial results for the first quarter of 2026 before the market opens on Thursday, April 30, 2026, and will host a conference call and webcast at 9:00 a.m. ET to discuss the results.
The earnings press release and financial information will be posted on the Labcorp Investor Relations website, where a link to the webcast and a replay available for one year will also be provided. Labcorp is described as a global leader in laboratory services, with nearly 71,000 employees serving clients in about 100 countries.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Earnings release date: April 30, 2026
Earnings call time: 9:00 a.m. ET
Employees: nearly 71,000 employees
+3 more
6 metrics
Earnings release date
April 30, 2026
First quarter 2026 results before market open
Earnings call time
9:00 a.m. ET
Webcast to discuss Q1 2026 results
Employees
nearly 71,000 employees
Global workforce as described in company overview
Geographic reach
approximately 100 countries
Clients served worldwide
Tests performed
more than 750 million tests
Annual testing volume for patients worldwide
FDA support share
more than 85%
Share of new drugs and therapeutic products approved by FDA in 2025 supported
Key Terms
webcast, Investor Relations website, laboratory services, Inline XBRL
4 terms
webcast financial
"will host a webcast beginning at 9:00 a.m. ET that day to discuss the results"
A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.
Investor Relations website financial
"The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website"
An investor relations website is a company's online page where it shares important information with current and potential investors, like financial results, company news, and future plans. It’s like a company’s official report card that helps people understand how the business is doing and decide whether to invest or stay informed.
laboratory services financial
"a global leader of innovative and comprehensive laboratory services"
Inline XBRL technical
"Exhibit 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
(Date of earliest event reported)
(Exact Name of Registrant as Specified in its Charter)
| (State or other jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
| , | ||||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||
(Registrant’s telephone number including area code) 336 -229-1127
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Exchange Act.
| Title of each class | Trading Symbol | Name of exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 7.01. | Regulation FD Disclosure. | ||||
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on March 31, 2026 that it will release its financial results for the first quarter of 2026 before the market opens on Thursday, April 30, 2026, and will host a conference call and webcast beginning at 9:00 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
A copy of the press release dated March 31, 2026 is furnished as Exhibit 99.1 hereto and incorporated by reference herein.
| Item 9.01. | Financial Statements and Exhibits. | |||||||
| Exhibit | Exhibit Name | |||||||
| Exhibit 99.1 | Press release dated March 31, 2026 issued by Labcorp Holdings Inc. | |||||||
| Exhibit 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LABCORP HOLDINGS INC.
Registrant
| Date: March 31, 2026 | By: | /s/ KATHRYN W. KYLE | ||||||
| Kathryn W. Kyle | ||||||||
| Executive Vice President, Chief Legal Officer and Corporate Secretary | ||||||||
FOR IMMEDIATE RELEASE
| Media | Investor Relations | |||||||
| Neil Hirsch | Dewey Steadman | |||||||
| Media@Labcorp.com | Investor@Labcorp.com | |||||||
Labcorp to Announce First Quarter Financial Results on April 30, 2026
BURLINGTON, N.C., (March 31, 2026) – Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first quarter of 2026 before the market opens on Thursday, April 30, 2026. The company will host a webcast beginning at 9:00 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the “News & Events” section of the Labcorp Investor Relations website at https://ir.labcorp.com. A link to the earnings webcast will also be available on the investor relations website.
A replay of the webcast will be available on the “News & Events” section of the investor relations website approximately two hours after the conclusion of the live event and will be available for one year.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than 85% of the new drugs and therapeutic products approved by the FDA in 2025, and performed more than 750 million tests for patients around the world. Learn more at https://www.labcorp.com/.
FAQ
When will Labcorp (LH) report its first quarter 2026 financial results?
Labcorp will release its first quarter 2026 financial results on Thursday, April 30, 2026, before the market opens. The company will also host a webcast at 9:00 a.m. ET that day to discuss the results in more detail.
How can investors access Labcorp’s Q1 2026 earnings webcast?
Investors can access Labcorp’s Q1 2026 earnings webcast through a link on the Labcorp Investor Relations website. The webcast begins at 9:00 a.m. ET on April 30, 2026, and will cover the company’s first quarter financial results.
Will a replay of Labcorp’s Q1 2026 earnings webcast be available?
Yes, a replay of Labcorp’s Q1 2026 earnings webcast will be available on the “News & Events” section of the Investor Relations website. It will be posted about two hours after the live event and remain accessible for one year.
Where will Labcorp post its Q1 2026 earnings press release and financial information?
Labcorp will post its Q1 2026 earnings press release and accompanying financial information on the “News & Events” section of its Investor Relations website. This online location will also provide access to the live webcast and replay details.
What does Labcorp (LH) say about its global laboratory services business?
Labcorp describes itself as a global leader in innovative and comprehensive laboratory services. The company helps healthcare providers and researchers make decisions through diagnostics and drug development capabilities, serving clients in about 100 countries across multiple healthcare and life science settings.
How extensive is Labcorp’s operational scale according to this disclosure?
Labcorp reports having nearly 71,000 employees serving clients in approximately 100 countries. It states that it supported more than 85% of new drugs and therapeutic products approved by the FDA in 2025 and performed more than 750 million tests worldwide.